Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Tags Biotech and Pharmaceuticals LILLY DRN Business
From CNBC.com News
Cramer's Lightning Round: Sunoco is a buy
Tags U/S/ Markets Mad Money Investment Strategy
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags LILLY DRN CVS Health Corp Biotech and Pharmaceuticals
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Tags World Economy US: News Deere & Co
From CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Tags Biotech and Pharmaceuticals Social issues Pfizer Inc
From CNBC.com News
Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad
Tags Internet Health care industry Breaking News: Technology
From CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Tags US: News Pharmaceuticals Health care industry
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Earnings
From CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
Tags Earnings Biotechnology Business
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags LILLY DRN Healthy Returns Social issues
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags Chipotle Mexican Grill Inc Investing Bristol/Myers Squibb Co
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags Pharmaceuticals US: News Health care industry
From CNBC.com News
World's largest luxury group LVMH posts better than feared full-year sales
Tags Burberry Group PLC Europe Markets Retail industry
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags Venture capital Social issues Medicare
From CNBC.com News
Novo Nordisk shares pop 10% on early-stage weight loss drug trial results
Tags Novo Nordisk A/S Breaking News: Europe Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Tags Johnson & Johnson Social issues Healthy Returns
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags LILLY DRN Pharmaceuticals World Economy
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags Hospitals Illumina Inc Novo Nordisk A/S
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Pharmaceuticals Theravance Biopharma Inc Bristol/Myers Squibb Co
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags LILLY DRN Biotech and Pharmaceuticals Business News
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Zillow Group Inc Pharmaceuticals LILLY DRN
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags Novo Nordisk A/S Biotechnology Business
From CNBC.com News
Cramer's Lightning Round: 'I'd be careful' with Novo Nordisk
Tags Novo Nordisk A/S Business Business News
From CNBC.com News
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
Tags Breaking News: Technology Tempus AI Inc Novo Nordisk A/S
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags LILLY DRN Biotech and Pharmaceuticals Business News
From CNBC.com News
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
Tags Daily Open Novo Nordisk A/S Market Outlook
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Business News Science Novo Nordisk A/S
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Tags Novo Nordisk A/S Breaking News: Markets Breaking News: Europe
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Health & Science Health care industry Pharmaceuticals
From CNBC.com News
Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch
Tags Sage Group PLC Markets Prices
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.